Updated April 16, 2019

InMed Pharmaceuticals

InMed Pharmaceuticals ("InMed") was founded in 2014 and is based in Vancouver, British Columbia. The company has three primary areas of focus: 1) developing cannabinoid-based pharmaceuticals, 2) manufacturing cannabinoids through biosynthesis, 3) discovering treatments through bioinformatics.

Latest Trading

$0.33
5.71%
(-0.02)
Open 0.36
Previous Close 0.35
Today's Range
0.33 0.36
52 Week Range
0.22 0.80
Volume 148.85K
Equity Market Value $73.36M
Dividend Yield 0.00
Loading Chart...

Latest Trading

$0.26
4.89%
(-0.01)
Open 0.26
Previous Close 0.27
Today's Range
0.24 0.27
52 Week Range
0.16 0.63
Volume 200.80K
Equity Market Value $57.06M
Dividend Yield 0.00
Loading Chart...